Medication use by U.S. Crewmembers on the International space station

FASEB Journal

Volumn 29, Issue 11, 2015, Pages 4417-4423

  Wotring, Virginia E ^a  

^a UNIVERSITIES SPACE RESEARCH ASSOCIATION   (United States)

Author keywords

Astronaut; Medicine; Microgravity; Pharmaceutical; Spaceflight

Indexed keywords

ACETYLSALICYLIC ACID; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; CORTICOSTEROID; DECONGESTIVE AGENT; HISTAMINE RELEASE INHIBITOR; MELATONIN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; ZALEPLON; ZOLPIDEM;

ADULT; ALLERGY; ARTICLE; COSMONAUT; DRUG EFFICACY; HUMAN; MEDICAL RECORD REVIEW; MEDICATION THERAPY MANAGEMENT; NORMAL HUMAN; PAIN; PRESCRIPTION; PRIORITY JOURNAL; RASH; RETROSPECTIVE STUDY; SINUS CONGESTION; SLEEP DISORDER; SPACE FLIGHT; TREATMENT FAILURE; TREATMENT INDICATION; AEROSPACE MEDICINE; FEMALE; MALE;

ADULT; AEROSPACE MEDICINE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; HUMANS; MALE; SPACE FLIGHT;

EID: 84948772416     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-264838     Document Type: Article

References (32)

1. Clement, G. (2003) Fundamentals of Space Medicine, Microcosm and Kluwer, El Segundo, CA, USA.
2. Buckey, J. C. (2006) Space Physiology, Oxford University Press, New York.
3. Crucian, B., and Sams, C. (2009) Immune system dysregulation during spaceflight: clinical risk for exploration-class missions. J. Leukoc. Biol. 86, 1017-1018.
4. Platts, S. (2010) Risk of Cardiac Rhythm Problems During Spaceflight (Nasa, H., ed.), Human Research Program: Human Health Countermeasures, NASA, Houston, TX. Available at http://humanresearchroadmap.nasa.gov/evidence/reports/Cardiac%20Rhythm.pdf?rnd=0.200512975547702.
5. Hargens, A. R., and Richardson, S. (2009) Cardiovascular adaptations, fluid shifts, and countermeasures related to space flight. Respir. Physiol. Neurobiol. 169(Suppl 1), S30-S33.
6. Hargens, A. R., and Watenpaugh, D. E. (1996) Cardiovascular adaptation to spaceflight. Med. Sci. Sports Exerc. 28, 977-982.
7. Brunner, L. J., DiPiro, J. T., and Feldman, S. (1995) Antipyrine pharmacokinetics in the tail-suspended rat model. J. Pharmacol. Exp. Ther. 274, 345-352.
8. Cucinotta, F. A., Kim, M. H., Willingham, V., and George, K. A. (2008) Physical and biological organ dosimetry analysis for international space station astronauts. Radiat. Res. 170, 127-138.
9. James, J., Meyers, V., Sipes, W., Scully, R., andMatty, C. (2011) Crew health and performance improvements with reduced carbon dioxide levels and the resources impact to accomplish those reductions. 41st International Conference on Environmental Systems. Available at http://arc.aiaa.org/doi/abs/10.2514/6.2011-5047.
10. Kelly, T.H., Hienz, R.D., Zarcone, T. J., Wurster, R.M., and Brady, J. V. (2005) Crewmember performance before, during, and after spaceflight. J. Exp. Anal. Behav. 84, 227-241.
11. Davis, J. R., Vanderploeg, J. M., Santy, P. A., Jennings, R. T., and Stewart, D. F. (1988) Space motion sickness during 24 flights of the space shuttle. Aviat. Space Environ. Med. 59, 1185-1189.
12. Barger, L. K., Flynn-Evans, E. E., Kubey, A., Walsh, L., Ronda, J. M., Wang, W., Wright, K. P. Jr., and Czeisler, C. A. (2014) Prevalence of sleepdeficiency anduseofhypnotic drugs inastronautsbefore, during, and after spaceflight: An observational study. Lancet Neurol. 13, 904-912.
13. Czeisler, C. A., Chiasera, A. J., and Duffy, J. F. (1991) Research on sleep, circadian rhythms and aging: Applications to manned spaceflight. Exp. Gerontol. 26, 217-232.
14. Kaufman, D. W., Kelly, J. P., Rosenberg, L., Anderson, T. E., and Mitchell, A. A. (2002) Recent patterns of medication use in the ambulatory adult population of the United States: The Slone survey. JAMA 287, 337-344.
15. Wing, P.C., Tsang, I. K., Susak, L., Gagnon, F., Gagnon, R., andPotts, J. E. (1991) Back pain and spinal changes in microgravity. Orthop. Clin. North Am. 22, 255-262.
16. Putcha, L., Berens, K. L., Marshburn, T. H., Ortega, H. J., and Billica, R. D. (1999) Pharmaceutical use by U.S. astronauts on space shuttle missions. Aviat. Space Environ. Med. 70, 705-708.
17. Horn, W. G., Thomas, T. L., Marino, K., and Hooper, T. I. (2003) Health experience of 122 submarine crewmembersduring a 101-day submergence. Aviat. Space Environ. Med. 74, 858-862.
18. Ortega, H. J. J., and Harm, D. L. (2008) Space and entry motion mickness. InPrinciples ofClinicalMedicine for Space Flight (Barrat, M.R., Pool, S. L., eds.) pp. 211-222, Springer, New York.
19. Graybiel, A., and Knepton, J. (1976) Sopite syndrome: A sometimes sole manifestation of motion sickness. Aviat. Space Environ. Med. 47, 873-882.
20. Scheuring, R. A., Mathers, C.H., Jones, J. A., andWear, M. L. (2009) Musculoskeletal injuries and minor trauma in space: incidence and injury mechanisms in U.S. astronauts. Aviat. Space Environ. Med. 80, 117-124.
21. Crucian, B., Stowe, R., Mehta, S., Uchakin, P., Quiriarte, H., Pierson, D., and Sams, C. (2008) Immune system dysregulation occurs during short duration spaceflight on board the space shuttle. J. Clin. Immunol. 33, 456-465.
22. French, D. P., and James, D. H. (2008) Reasons for the use of mild analgesics among English students. Pharm. World Sci. 30, 79-85.
23. Strauss, S., Krog, R. L., and Feiveson, A. H. (2005) Extravehicular mobility unit training and astronaut injuries. Aviat. Space Environ. Med. 76, 469-474.
24. Martelletti, P., Steiner, T. J., Bertolote, J.M., Dua, T., andSaraceno, B. (2007) The definitive position of headache among themajor public health challenges. An end to the slippery slope of disregard. J. Headache Pain 8, 149-151.
25. Steiner, T. J., Paemeleire, K., Jensen, R., Valade, D., Savi, L., Lainez, M. J., Diener, H. C., Martelletti, P., and Couturier, E. G.; European Headache Federation; LiftingTheBurden:TheGlobalCampaign to Reduce the Burden of Headache Worldwide; World Health Organization. (2007) European principles of management of common headache disorders in primary care. J. Headache Pain 8 (Suppl 1), S3-S47.
26. Castro, V.A., Thrasher, A.N., Healy, M., Ott, C.M., andPierson, D.L. (2004) Microbial characterization during the early habitation of the International Space Station. Microb. Ecol. 47, 119-126.
27. Crucian, B., Stowe, R. P., Ott, C. M., Becker, J. L., Haddon, R., McMonigal, K. A., and Sams, C. F. (2009)Risk of crew adverse health event due to altered immune response. NASA Human Research Program, Houston, TX. Available at http://humanresearchroadmap.nasa.gov/evidence/reports/immune.pdf.
28. Mehta, S. K., Cohrs, R. J., Forghani, B., Zerbe, G., Gilden, D.H., and Pierson, D. L. (2004) Stress-induced subclinical reactivation of varicella zoster virus in astronauts. J. Med. Virol. 72, 174-179.
29. Pierson, D. L., Stowe, R. P., Phillips, T. M., Lugg, D. J., and Mehta, S. K. (2005) Epstein-Barr virus shedding by astronauts during space flight. Brain Behav. Immun. 19, 235-242.
30. Jan, M. H., Thomas, T. L., and Hooper, T. I. (2002) Prescription medication use aboard US submarines during periods underway. Undersea Hyperb. Med. 29, 294-306.
31. DeMers, G., Horn, W.G., and Hughes, L. M. (2009) Assessment of headache incidence during SURVIVEX2004. Naval Submarine Medical Research Laboratory, Groton, CT.
32. Margel, D., White, D.P., and Pillar, G. (2003)Long-termintermittent exposure to high ambient CO2 causes respiratory disturbances during sleep in submariners. Chest 124, 1716-1723.